Digital Therapeutics - India

  • India
  • Revenue in the Digital Therapeutics market is projected to reach US$149.50m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 18.68%, resulting in a projected market volume of US$296.60m by 2028.
  • User penetration will be 0.81% in 2024 and is expected to hit 1.37% by 2028.
  • The average revenue per user (ARPU) is expected to amount to US$12.96.
  • In global comparison, most revenue will be generated in the United States (US$3,147.00m in 2024).

Key regions: Japan, United States, India, France, United Kingdom

Region comparison

Analyst Opinion

The Digital Therapeutics market in India is showing promising growth, driven by increasing awareness about the benefits of digital solutions in healthcare and the rising prevalence of chronic diseases in the country.

Customer preferences:
Customers in India are increasingly turning to digital therapeutics products for managing chronic conditions such as diabetes, mental health disorders, cardiovascular diseases, and musculoskeletal issues. The convenience, accessibility, and cost-effectiveness of these digital solutions are appealing to a tech-savvy population looking for efficient ways to monitor and improve their health.

Trends in the market:
In India, there is a noticeable trend towards the adoption of digital therapeutics solutions, especially among urban populations with access to smartphones and the internet. Companies offering products focused on diabetes care, mental health, cardiovascular health, and musculoskeletal health are seeing growing demand as more people seek personalized and data-driven approaches to managing their health conditions.

Local special circumstances:
One of the key factors driving the growth of the Digital Therapeutics market in India is the increasing penetration of smartphones and the internet across the country. With a large population that is becoming more health-conscious, there is a growing demand for digital tools that can provide real-time monitoring, personalized recommendations, and virtual consultations. Additionally, the government's push towards digital healthcare initiatives and the rise of telemedicine services are creating a conducive environment for the adoption of digital therapeutics in India.

Underlying macroeconomic factors:
The Digital Therapeutics market in India is also influenced by macroeconomic factors such as the increasing healthcare expenditure, the growing middle-class population with disposable income, and the expanding private healthcare sector. As more healthcare providers and insurance companies recognize the value of digital therapeutics in improving patient outcomes and reducing healthcare costs, the market is expected to witness further growth and innovation in the coming years.


Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market market. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.


  • Revenue
  • Analyst Opinion
  • Users
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)